Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study

Shereen, 2020, COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses, J Adv Res, 24, 91, 10.1016/j.jare.2020.03.005 Lillie, 2020, Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission, J Infect, 80, 578, 10.1016/j.jinf.2020.02.020 Hadjidemetriou, 2020, The impact of government measures and human mobility trend on COVID-19 related deaths in the UK, Transp Res Interdiscip Perspect, 6 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Voysey, 2021, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, Lancet, 397, 99, 10.1016/S0140-6736(20)32661-1 Biggerstaff, 2014, Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature, BMC Infect Dis, 14, 480, 10.1186/1471-2334-14-480 Moore, 2020, Modelling optimal vaccination strategy for SARS-CoV-2 in the UK, medRxiv Bubar, 2021, Model-informed COVID-19 vaccine prioritization strategies by age and serostatus, Science, 371, 916, 10.1126/science.abe6959 Matrajt, 2021, Optimizing vaccine allocation for COVID-19 vaccines: critical role of single-dose vaccination, medRxiv Keeling, 2020, Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number, medRxiv Jayasooriya, 2020, Seasonal influenza programme expansion, BMJ, 371 Voysey, 2021, Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials, Lancet, 397, 881, 10.1016/S0140-6736(21)00432-3 Davies, 2020, Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012/01 in England, medRxiv Bachtiger, 2020, Inadequate intention to receive Covid-19 vaccination: indicators for public health messaging needed to improve uptake in UK, medRxiv Keeling, 1999, The effects of local spatial structure on epidemiological invasions, Proc R Soc Lond B, 266, 859, 10.1098/rspb.1999.0716 Bish, 2011, Factors associated with uptake of vaccination against pandemic influenza: a systematic review, Vaccine, 29, 6472, 10.1016/j.vaccine.2011.06.107 Sherman, 2020, COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey, Hum Vaccin Immunother Bonsall, 2021, Optimal time to return to normality: parallel use of COVID-19 vaccines and circuit breakers, medRxiv de Figueiredo, 2020, Sub-national forecasts of COVID-19 vaccine acceptance across the UK: a large-scale cross-sectional spatial modelling study, medRxiv Weitz, 2020, Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations, Proc Natl Acad Sci USA, 117, 32 764, 10.1073/pnas.2009911117 Baden, 2020, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine, N Engl J Med, 384, 403, 10.1056/NEJMoa2035389 Brieger, 1991, Guineaworm control case study: planning a multi-strategy approach, Soc Sci Med, 32, 1319, 10.1016/0277-9536(91)90191-E Contreras, 2021, The challenges of containing SARS-CoV-2 via test-trace-and-isolate, Nat Commun, 12, 378, 10.1038/s41467-020-20699-8 Saad-Roy, 2021, Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes, medRxiv